Touyun Biotech Group Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was HKD 72.95 million compared to HKD 168.78 million a year ago. Basic loss per share from continuing operations was HKD 0.0261 compared to HKD 0.0632 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 HKD | 0.00% | 0.00% | 0.00% |
Apr. 30 | China Touyun Tech Widens Loss in 2023 Amid Lower Sales Orders | MT |
Mar. 28 | Touyun Biotech Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 82.62M | |
+19.25% | 21.59B | |
+9.59% | 17.85B | |
-10.47% | 9.84B | |
+19.47% | 9.34B | |
-3.70% | 5.12B | |
+2.28% | 4.94B | |
-4.10% | 2.99B | |
+12.13% | 2.98B | |
-1.02% | 2.43B |
- Stock Market
- Equities
- 1332 Stock
- News Touyun Biotech Group Limited
- Touyun Biotech Group Limited Reports Earnings Results for the Full Year Ended December 31, 2021